Vaxart, Inc. Advances to OTCQX Market
Vaxart, Inc. (OTCQX: VXRT), a pioneering clinical-stage biotechnology company, has officially transitioned to the OTCQX Best Market. Previously listed on NASDAQ, this move marks a significant milestone in the company's journey to enhance its presence in the U.S. capital markets.
Trading Symbol and Transparency
Effective immediately, Vaxart will trade under the symbol VXRT. Investors in the United States can seamlessly access various financial disclosures and real-time Level 2 quotes through the OTC Markets website. This transition reflects not only a change in trading venues but also a commitment to enhanced transparency for investors.
Benefits of Trading on OTCQX
The OTCQX Best Market provides a range of benefits for companies like Vaxart, including efficient access to capital and lower operational costs. The streamlined requirements for listing help reduce complexities while promoting transparency in trading. Companies are held to high financial standards and superior corporate governance practices, ensuring that they meet the necessary qualifications for this esteemed trading venue.
CEO Statement on Transition
Steven Lo, the CEO of Vaxart, expressed gratitude towards OTC Markets Group for this opportunity and acknowledged the unwavering support of their investors. He emphasized the company’s focused mission to advance innovative oral pill vaccines, which hold the potential to significantly impact public health initiatives.
About Vaxart, Inc.
Vaxart specializes in developing a unique range of oral recombinant vaccines leveraging its proprietary delivery platform. Their innovative pill vaccines are designed for easy storage and transport without the need for refrigeration, thus eliminating the hazards associated with needle-stick injuries. Vaxart's technology is engineered to support oral delivery of recombinant vaccines, enabling the company to expand its portfolio with novel vaccine candidates aimed at various serious diseases.
Current Development Programs
Among their exciting projects, Vaxart is working on pill vaccines targeting significant health challenges, including coronavirus, norovirus, and influenza. Additionally, Vaxart is developing a therapeutic vaccine aimed at human papillomavirus (HPV), marking its foray into immune-oncology. Their commitment to research and development is further demonstrated by the extensive patent applications filed in both domestic and international markets, safeguarding their innovative approach to oral vaccination.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) runs regulated trading markets for over 12,000 U.S. and international securities. Their platforms, including OTCQX and OTCQB, provide critical infrastructure for brokers and facilitate efficient trading. This corporate structure allows companies, like Vaxart, to tap into the U.S. financial landscape with greater ease.
Market Innovations
OTC Markets employs a data-driven approach to maintain public market efficiency. The innovative infrastructure, including the OTC Link® Alternative Trading Systems, empowers broker-dealers and ensures a smooth trading experience for investors. For firms seeking a dependable marketplace, the OTCQX Best Market stands out as a favorable destination.
Frequently Asked Questions
What does Vaxart do?
Vaxart is a clinical-stage biotechnology company focused on developing oral vaccines that provide safer and more efficient vaccination methods.
Why did Vaxart transition to OTCQX?
The shift to OTCQX allows Vaxart to access capital markets more efficiently while adhering to high financial and governance standards.
What is the significance of the VXRT trading symbol?
The VXRT symbol represents Vaxart on the OTCQX platform, enabling U.S. investors to easily identify and trade their shares.
What types of vaccines is Vaxart developing?
Vaxart is developing vaccines to protect against various viruses, including COVID-19, influenza, and HPV, emphasizing oral delivery methods.
How does OTC Markets Group support companies like Vaxart?
OTC Markets Group provides a regulated trading environment that facilitates efficient access to capital and upholds transparency in financial reporting.
